Fleur M. Moesker

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial

Joost H. C. M. Kreijtz, Marco Goeijenbier, Fleur M. Moesker et al. · The Lancet Infectious Diseases · 2014 · 93 citations

Vaccination, Double-blind Phase 1/2A, Vaccine Development +6

Human bocavirus infection as a cause of severe acute respiratory tract infection in children

Fleur M. Moesker, Jeroen J. A. van Kampen, Annemiek A. van der Eijk et al. · Clinical Microbiology and Infection · 2015 · 76 citations · Full text

Respiratory Diseases, Pediatrics, Respiratory Infection +6

Diagnostic performance of influenza viruses and RSV rapid antigen detection tests in children in tertiary care

Fleur M. Moesker, Jeroen J. A. van Kampen, Georgina I. Aron et al. · Journal of Clinical Virology · 2016 · 41 citations · Full text

Viruses as Sole Causative Agents of Severe Acute Respiratory Tract Infections in Children

Fleur M. Moesker, Jeroen J. A. van Kampen, Annemarie M. C. van Rossum et al. · PLoS ONE · 2016 · 36 citations · Full text